HuGE Literature Finder
Records 1-14
Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
Annals of surgical oncology 2018 Jul 25 (7): 2027-2033. van Beek Elke J A H, Hernandez Jonathan M, Goldman Debra A, Davis Jeremy L, McLaughlin Kaitlin, Ripley R Taylor, Kim Teresa S, Tang Laura H, Hechtman Jaclyn F, Zheng Jian, Capanu Marinela, Schultz Nikolaus, Hyman David M, Ladanyi Marc, Berger Michael F, Solit David B, Janjigian Yelena Y, Strong Vivian |
HPV Status and Mutation Analysis Using Multiparallel Sequencing in Distal Oesophageal and Gastro-oesophageal Junction Adenocarcinomas.
Folia biologica 2018 64 (2): 41-45. Vošmik M, Vošmiková H, Sieglová K, Sirák I, Laco J, Ryška A, Petera J, Melichar B, Soumarová |
Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary.
Molecular and clinical oncology 2016 Oct 5 (4): 395-401. Kato Masafumi, Takano Masashi, Miyamoto Morikazu, Sasaki Naoki, Goto Tomoko, Suzuki Ayako, Hirata Junko, Sasa Hidenori, Tsuda Hitoshi, Furuya Kenic |
Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas.
American journal of clinical pathology 2016 Jun 145 (6): 815-25. Sasaki Motoko, Nitta Takeo, Sato Yasunori, Nakanuma Yasu |
Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
Human pathology 2016 Mar . Pyo Jung-Soo, Sohn Jin Hee, Kang Guhy |
Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/?-catenin signaling pathway mutations.
Cancer 2016 Mar . Yuan Wei, Zhang Zhou, Dai Binghua, Wei Qing, Liu Jinjin, Liu Yuzhen, Liu Yun, He Lin, Zhou Daizh |
Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Sep . Mirkovic Jelena, Sholl Lynette M, Garcia Elizabeth, Lindeman Neal, MacConaill Laura, Hirsch Michelle, Dal Cin Paola, Gorman Melissa, Barletta Justine A, Nucci Marisa R, McCluggage W Glenn, Howitt Brooke |
Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
The Journal of pathology 2014 Mar 232 (4): 428-35. Jiao Yuchen, Yonescu Raluca, Offerhaus G Johan A, Klimstra David S, Maitra Anirban, Eshleman James R, Herman James G, Poh Weijie, Pelosof Lorraine, Wolfgang Christopher L, Vogelstein Bert, Kinzler Kenneth W, Hruban Ralph H, Papadopoulos Nickolas, Wood Laura |
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
Nature genetics 2013 May 45 (5): 478-86. Dulak Austin M, Stojanov Petar, Peng Shouyong, Lawrence Michael S, Fox Cameron, Stewart Chip, Bandla Santhoshi, Imamura Yu, Schumacher Steven E, Shefler Erica, McKenna Aaron, Carter Scott L, Cibulskis Kristian, Sivachenko Andrey, Saksena Gordon, Voet Douglas, Ramos Alex H, Auclair Daniel, Thompson Kristin, Sougnez Carrie, Onofrio Robert C, Guiducci Candace, Beroukhim Rameen, Zhou Zhongren, Lin Lin, Lin Jules, Reddy Rishindra, Chang Andrew, Landrenau Rodney, Pennathur Arjun, Ogino Shuji, Luketich James D, Golub Todd R, Gabriel Stacey B, Lander Eric S, Beer David G, Godfrey Tony E, Getz Gad, Bass Adam |
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.
Nature 2012 Oct . Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu C, Nones K, Lynn Fink J, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Scott Mead R, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Biankin AV, Johns AL, Mawson A, Chang DK, Scarlett CJ, Brancato MA, Rowe SJ, Simpson SL, Martyn-Smith M, Thomas MT, Chantrill LA, Chin VT, Chou A, Cowley MJ, Humphris JL, Jones MD, Scott Mead R, Nagrial AM, Pajic M, Pettit J, Pinese M, Rooman I, Wu J, Tao J, Dipietro R, Watson C, Wong R, Pinho AV, Giry-Laterriere M, Daly RJ, Musgrove EA, Sutherland RL, Grimmond SM, Waddell N, Kassahn KS, Miller DK, Wilson PJ, Patch AM, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu C, Nones K, Lynn Fink J, Christ A, Bruxner T, Cloonan N, Newell F, Pearson JV, Samra JS, Gill AJ, Pavlakis N, Guminski A, Toon C, Biankin AV, Asghari R, Merrett ND, Chang DK, Pavey DA, Das A, Cosman PH, Ismail K, O'Connor C, Lam VW, McLeod D, Pleass HC, Richardson A, James V, Kench JG, Cooper CL, Joseph D, Sandroussi C, Crawford M, Gallagher J, Texler M, Forrest C, Laycock A, Epari KP, Ballal M, Fletcher DR, Mukhedkar S, Spry NA, Deboer B, Chai M, Zeps N, Beilin M, Feeney K, Nguyen NQ, Ruszkiewicz AR, Worthley C, Tan CP, Debrencini T, Chen J, Brooke-Smith ME, Papangelis V, Tang H, Barbour AP, Clouston AD, Martin P, O'Rourke TJ, Chiang A, Fawcett JW, Slater K, Yeung S, Hatzifotis M, Hodgkinson P, Christophi C, Nikfarjam M, Mountain Victorian Cancer Biobank A, Eshleman JR, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Hodgin MB, Scarpa A, Lawlor RT, Capelli P, Beghelli S, Corbo V, Scardoni M, Pederzoli P, Tortora G, Bassi C, Tempero MA, Kakkar N, Zhao F, Qing Wu Y, Wang M, Muzny DM, Fisher WE, Charles Brunicardi F, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SM |
PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
Virchows Archiv : an international journal of pathology 2011 Nov . Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O |
Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
Cancer genomics & proteomics 0 17 (5): 627-641. Jung Hera, Bae Go Eun, Kim Hye Min, Kim Hyun-S |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: